Evaluation of Phenytoin Dosage Regimens Based on Genotyping of CYP2C Subfamily in Routinely Treated Japanese Patients††Financial support: This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Sciences (JSPS).-Reference-Cited by-同舟云学术

Evaluation of Phenytoin Dosage Regimens Based on Genotyping of CYP2C Subfamily in Routinely Treated Japanese Patients††Financial support: This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Sciences (JSPS).

Published:2005 Issue:2 Volume:20 Page:107-112
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Taguchi Masato,Hongou Kazuhisa,Yagi Shinichi,Miyawaki Toshio,Takizawa Miwako,Aiba Tetsuya,Hashimoto Yukiya

Publisher

Japanese Society for the Study of Xenobiotics

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference18 articles.

1. Antiepileptic drug review: part 1;Winkler;Surg. Neurol.,1998

2. Insufficient parahydroxylation as a cause of dephenylhydantoin toxicity;Kutt;Neurology,1964

3. Phenytoin: pharmacogenetic polymorphism of 4′-hydroxylation;Inaba;Pharmacol. Ther.,1990

4. Effect of CYP2C polymorphisms on the pharmacokinetics of phenytoin in Japanese patients with epilepsy;Hashimoto;Biol. Pharm. Bull.,1996

5. Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite;Bajpai;Drug Metab. Dispos.,1996

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs;JAMA Network Open;2024-08-08

2. A meta-analysis of effects of CYP2C9 and CYP2C19 polymorphisms on phenytoin pharmacokinetic parameters;Pharmacogenomics;2021-07

3. The Evolution of Population Pharmacokinetic Model of Oral Phenytoin for Early Seizure Prophylaxis Post-Craniotomy;Current Drug Metabolism;2019-10-04

4. Efficacy of antiepileptic drugs in the era of pharmacogenomics: A focus on childhood;European Journal of Paediatric Neurology;2019-09

5. CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy;The Pharmacogenomics Journal;2015-06-30